Cumberland Emerging Technologies Appoints Joseph O. Rolwing as New Board Member

May 25, 2022 at 07:32 pm by Staff

NASHVILLE – CumberlandEmerging Technologies, Inc.(CET) announced today the addition of Joseph O. Rolwing to its Board of Directors.
Rolwing is Senior Director at CET where he manages its Life Sciences Center, an incubator for early-stage biomedical ventures offering 14,000 square feet of laboratory and office space and equipment.
CET is a unique collaboration among Vanderbilt University, Cumberland Pharmaceuticals (NASDAQ: CPIX), Launch Tennessee and WinHealth Pharma. CET is designed to support the development of innovative new biomedical technologies, products and companies.
“Joe has established and built the Life Sciences Center into a vibrant community supporting the growth of the life science industry here in Middle Tennessee,” said A.J. Kazimi, CEO of both CET and Cumberland Pharmaceuticals. “We have more than doubled the facility’s square footage in recent years, and with Joe’s guidance, the center has served as a major catalyst in the creation of dozens of new businesses – and ultimately hundreds of new jobs. We are very pleased to welcome him to the Board of Directors and know his expertise will continue to contribute to CET’s success.”
Rolwing has nearly 40 years of health care experience. Prior to joining CET, he was Vice President and Business Manager at Genetics Associates, Inc., a multi-million dollar diagnostic medical laboratory. He has also served as Vice President of Corporate Affairs for the Centerstone Community Mental Health Centers, Inc. as well as Special Projects Director and Finance Director for the Helen Ross McNabb Center.
He earned his bachelor’s degree from Southeast Missouri State University and his master’s from the University of North Carolina Kenan-Flagler Business School.
CET’s board of directors also includes Kazimi; Alan R. Bentley, Assistant Vice Chancellor of Technology Transfer at Vanderbilt University; Kenneth J. Holroyd, Vice President of Technology Transfer at Vanderbilt University Medical Center; Wei Wang (Jack), CEO of WinHealth Pharmaceuticals and Samuel M. Lawrence, CEO and Co-founder of CytoViva, Inc.
Sections: Profiles